What is Amplify Partners?
Amplify Partners operates as a venture capital firm dedicated to investing in early-stage companies that are at the forefront of novel applications in machine intelligence and computer science. The firm distinguishes itself through its profound domain expertise and extensive network of leading technologists. This unique combination allows Amplify Partners to offer deep enterprise insight and effectively support technical founding teams. Notable portfolio companies include ClickDiagnostics, Cambridge Cancer Genomics, Notable Labs, and Recursion Pharmaceuticals, highlighting a consistent track record of identifying and nurturing high-potential technology startups.
How much funding has Amplify Partners raised?
Amplify Partners has raised a total of $49.1M across 1 funding round:
Debt
$49.1M
Debt (2012): $49.1M with participation from Sapphire Ventures
Key Investors in Amplify Partners
Sapphire Ventures
Sapphire Ventures is a venture capital firm based in Palo Alto, California, specializing in investments within the technology sector and providing associated services to its portfolio companies.
What's next for Amplify Partners?
The substantial enterprise-level funding and strategic investment received by Amplify Partners signal a robust growth trajectory and a commitment to expanding its influence within the early-stage technology investment sector. This capital infusion is expected to empower Amplify Partners to further enhance its investment capabilities, deepen its domain expertise in machine intelligence and computer science, and continue its mission of backing innovative companies that are shaping the future of technology. The firm's strategic focus on technical founding teams and its strong enterprise relationships position it for continued success in identifying and scaling disruptive technologies.
See full Amplify Partners company page
